Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.

By L. Adams, M. Bulsara, E. Rossi, B. Deboer, D. Speers, J. George, J. Kench, G. Farrell, G. McCaughan, G. Jeffrey. Clinical Chemistry, 2005

735 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/a38c419a82377d43dd6eec31ea8a7f73629018b1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. X. Forns

In Hepatology

1. X. Forns

Citations in the corpus

• EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. (2015, neutral): “HCV Fibrotest® (Biopredictive, Paris, France) patented formula combining α-2-macroglobulin, γGT, apolipoprotein A1, haptoglobin, total bilirubin, age and gender Forns Index = 7.811 - 3.131 x ln(platelet count) + 0.781 x ln(GGT) + 3.467 x ln(age) - 0.014 x (cholesterol) AST to Platelet Ratio (APRI) =”
• Noninvasive assessment of liver fibrosis (2011, background): “The combination of routine laboratory tests with fibrosis biomarkers may increase the accuracy for identifying cases of significant fibrosis and cirrhosis.(9,10,16) Although identification of individual fibrosis stages is still not possible, some of the published scores do allow the classification o”